Automation and sector-wide collaboration will be critical as developers try to move beyond the production challenges that slow growth of the cell and gene therapy sector. So says Julie G. Allickson, ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Cell and gene therapy (CGT) manufacturers can struggle to move from lab-scale to clinical-scale production. Automation can help but, to make a success of the transition, developers must be willing to ...

Genetic modification of mammalian cells has vast use in biotherapeutics development and basic research applications. An important step early on is the isolation of clones with the desired mutation ...

Cell therapy manufacturing has long been constrained by manual bottlenecks - steps that are labor-intensive, variable, and difficult to scale. Robotic automation is increasingly becoming key to ...

Flexible downstream automation work cells increase the value of molded parts while the parts are still beside the injection molding machine. Maintaining part integrity and orientation through ...

Spanning a wall in a separate area is a large automatic storage and retrieval system that feeds multiple lasers and stores ...